ArticleCEN case reports2026
Late-onset polyvinylpyrrolidone allergy in a long-term hemodialysis patient: a case report of dialysis hypotension and gastrointestinal symptoms.
Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polysulfone membranes are widely used in hemodialysis due to their excellent biocompatibility, with polyvinylpyrrolidone (PVP) serving as a key hydrophilic component. While PVP-related allergic reactions typically occur during initial exposure, delayed reactions in long-term dialysis patients present a unique diagnostic challenge due to their unexpected nature and similarity to routine complications. We report a case of delayed PVP allergy in a 69-year-old male who developed severe intradialytic hypotension and gastrointestinal symptoms after 13 months of stable hemodialysis treatment. Blood volume monitoring revealed a rapid 15% decrease within 30 min of dialysis initiation despite the absence of ultrafiltration, accompanied by marked eosinophilia (absolute eosinophil count: 13,266/μL) and elevated white blood cell count (19,800/μL). These symptoms persisted despite dry weight adjustments but resolved completely after switching from a polysulfone membrane to a PVP-free cellulose triacetate membrane. The patient's condition improved significantly, with eosinophil counts normalizing over nine months following the membrane change. This case contributes to the limited literature on delayed PVP allergic reactions, highlighting that such reactions can occur even after extended periods of stable dialysis. The successful use of blood volume monitoring and eosinophil tracking for early detection, combined with the effectiveness of PVP-free membrane substitution, provides valuable insights for managing similar cases. Recognition of this phenomenon may help improve the diagnosis and management of unexplained dialysis reactions in long-term patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.